CRISPR activation screening in a mouse model for drivers of hepatocellular carcinoma growth and metastasis
Authors:
Open Access
- 2 February 2023
- Vol. 26 (3) , 106099
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Liver Transplantation Versus Liver Resection in the Treatment of Hepatocellular CarcinomaTransplantation, 2014
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human CellsScience, 2014
- Origins of Metastatic TraitsCancer Cell, 2013
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Underutilization of therapy for hepatocellular carcinoma in the medicare populationCancer, 2010
- Epithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion†,‡Hepatology, 2010
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Racial and Geographic Disparities in the Utilization of Surgical Therapy for Hepatocellular CarcinomaJournal of Gastrointestinal Surgery, 2007
- The Gene (POLR2L) Encoding the hRPB7.6 Subunit of Human RNA PolymeraseGenomics, 1996